首页> 外国专利> THERAPEUTIC PEPTIDES HAVING A MOTIF THAT BINDS SPECIFICALLY TO NON-ACETYLATED H3 AND H4 HISTONES FOR CANCER THERAPY

THERAPEUTIC PEPTIDES HAVING A MOTIF THAT BINDS SPECIFICALLY TO NON-ACETYLATED H3 AND H4 HISTONES FOR CANCER THERAPY

机译:具有可与特定的非乙酰化H3和H4组蛋白结合的MOTIF的治疗性肽,可用于癌症治疗

摘要

The present invention describes a composition of matter comprising a conservedstructural motif that allows the targeting and binding of a chromatin bindingprotein to non-acetylated histone H3 and H4 and prevents their acetylation.This invention is responsible for the anti-carcinogenic property of achromatin binding peptide isolated from soybean seed. This structural motif isfound in a highly conserved manner in other chromatin-binding proteins fromdifferent species. Modifications to this structural motif such as fusions toother proteins with functional motifs and amino acid substitutions havepotential therapeutic applications and can be developed as an in vivo genesilencing technology for biological and medical research. In particular,active fragments of the lunasin peptide and active analogs of the lunasinpeptide are useful in this invention. Pharmaceutical compositions useful inretarding or stopping or reducing various types of cancers are described.
机译:本发明描述了包含保守的物质组成可以靶向和结合染色质结合的结构基序蛋白质可将其还原为非乙酰化的组蛋白H3和H4,并阻止其乙酰化。本发明负责一种抗癌药。从大豆种子分离的染色质结合肽。这个结构主题是以高度保守的方式发现于其他染色质结合蛋白中不同的物种。对该结构基序的修饰,例如与其他具有功能性基序和氨基酸取代的蛋白质具有潜在的治疗应用,可以作为体内基因开发用于生物学和医学研究的沉默技术。特别是,Lunasin肽的活性片段和Lunasin的活性类似物肽可用于本发明。可用于描述了延迟或停止或减少各种类型的癌症。

著录项

  • 公开/公告号CA2404100A1

    专利类型

  • 公开/公告日2001-10-04

    原文格式PDF

  • 申请/专利权人 FILGEN BIOSCIENCES INC.;

    申请/专利号CA20012404100

  • 发明设计人 GALVEZ ALFREDO F.;

    申请日2001-03-23

  • 分类号C07K14/415;A61P35/00;A61K38/16;C12N15/29;

  • 国家 CA

  • 入库时间 2022-08-22 01:21:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号